Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NY:BTX)

7.500 +0.270 (+3.73%)
Official Closing Price Updated: 7:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,536,831
Open 7.190
Bid (Size) 7.000 (1)
Ask (Size) 7.440 (3)
Prev. Close 7.230
Today's Range 7.110 - 7.500
52wk Range 5.100 - 8.120
Shares Outstanding 62,363,763
Dividend Yield 12.96%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BlackRock Technology and Private Equity Term Trust (BTX) Announces Final Results of Tender Offer
From BlackRock Closed-End Funds
Via Business Wire
BlackRock Technology and Private Equity Term Trust (BTX) Announces Expiration and Preliminary Results of Tender Offer
From BlackRock Closed-End Funds
Via Business Wire

Performance

YTD
-4.6%
-4.6%
1 Month
+5.5%
+5.5%
3 Month
+27.3%
+27.3%
6 Month
-4.6%
-4.6%
1 Year
-4.6%
-4.6%

More News

Read More
BlackRock Technology and Private Equity Term Trust (BTX) Commences Tender Offer for up to 50% of outstanding common shares
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
BlackRock Announces Shareholder Approval of Strategy Changes to the BlackRock Technology and Private Equity Term Trust (BTX)
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
From BlackRock Closed-End Funds
Via Business Wire
Certain BlackRock Closed-End Funds Announce Renewal of Discount Management Programs
From BlackRock Closed-End Funds
Via Business Wire

Frequently Asked Questions

Is Brooklyn ImmunoTherapeutics, Inc. - Common Stock publicly traded?
Yes, Brooklyn ImmunoTherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Brooklyn ImmunoTherapeutics, Inc. - Common Stock trade on?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The ticker symbol for Brooklyn ImmunoTherapeutics, Inc. - Common Stock is BTX on the New York Stock Exchange
What is the current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The current price of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 7.500
When was Brooklyn ImmunoTherapeutics, Inc. - Common Stock last traded?
The last trade of Brooklyn ImmunoTherapeutics, Inc. - Common Stock was at 07/18/25 07:00 PM ET
What is the market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock?
The market capitalization of Brooklyn ImmunoTherapeutics, Inc. - Common Stock is 467.73M
How many shares of Brooklyn ImmunoTherapeutics, Inc. - Common Stock are outstanding?
Brooklyn ImmunoTherapeutics, Inc. - Common Stock has 468M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.